California State Teachers Retirement System (CalSTRS)’s Mineralys Therapeutics MLYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Buy
67,221
+5,955
+10% +$163K ﹤0.01% 1635
2026
Q1
$1.66M Buy
61,266
+17,918
+41% +$525K ﹤0.01% 1627
2025
Q4
$1.57M Buy
43,348
+6,749
+18% +$271K ﹤0.01% 1556
2025
Q3
$1.39M Buy
36,599
+7
+0% +$151 ﹤0.01% 1613
2025
Q2
$495K Buy
36,592
+34,523
+1,669% +$500K ﹤0.01% 2059
2025
Q1
$32.9K Hold
2,069
﹤0.01% 2398
2024
Q4
$25.5K Hold
2,069
﹤0.01% 2531
2024
Q3
$25.1K Hold
2,069
﹤0.01% 2534
2024
Q2
$24.2K Buy
2,069
+116
+6% +$1.46K ﹤0.01% 2530
2024
Q1
$25.2K Sell
1,953
-1,244
-39% -$15.4K ﹤0.01% 2635
2023
Q4
$27.5K Buy
3,197
+118
+4% +$927 ﹤0.01% 2816
2023
Q3
$29.3K Sell
3,079
-1,563
-34% -$20.4K ﹤0.01% 2903
2023
Q2
$79.1K Buy
4,642
+143
+3% +$2.14K ﹤0.01% 2731
2023
Q1
$70.5K Buy
+4,499
New +$75.7K ﹤0.01% 2768

Other funds holding MLYS

California State Teachers Retirement System (CalSTRS)'s MLYS Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Mineralys Therapeutics (MLYS) stake by 9.7% in Q2 2026, buying an estimated $163K and bringing the position to 67,221 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1635.

California State Teachers Retirement System (CalSTRS) first reported a position in MLYS in Q1 2023 and has held it in 14 quarters since. 226 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 67,221 shares of Mineralys Therapeutics worth $1.81M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) bought 5,955 Mineralys Therapeutics shares in Q2 2026, an estimated $163K.
  • Mineralys Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1635 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Mineralys Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • 226 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.